论文部分内容阅读
目的观察痰热清注射液治疗小儿急性呼吸道感染的临床疗效。方法对2005年1月至2009年1月226例急性呼吸道感染住院患儿,采用随机的方法分两组,即痰热清组和必嗽平对照组,实验组114例给予痰热清注射液0.3～0.5 m1/(kg.次)(最大20 m l次/),1次/d。对照组112例使用针剂必嗽平4～8 mg次/,每日1次。两组患儿连续使用7 d为一疗程。结果实验组显效率为65%,总有效率88.7%,均优于对照组。结论痰热清注射液治疗儿童急性呼吸道感染疗效显著,安全性好,值得在儿科推广应用。
Objective To observe the clinical effect of Tanreqing Injection in treating children acute respiratory infection. Methods A total of 226 hospitalized children with acute respiratory infection from January 2005 to January 2009 were randomly divided into two groups: Tanreqing tablet group and CBF control group. 114 cases in the experimental group were given Tanreqing injection 0.3 ~ 0.5 m1 / (kg times) (maximum 20 ml times /), 1 time / d. In the control group, 112 cases were given cough for 4-8 mg once daily and once daily. The two groups of children with continuous use of 7d for a course of treatment. Results The experimental group markedly effective rate was 65%, the total effective rate was 88.7%, were better than the control group. Conclusion Tanreqing Injection has a significant therapeutic effect on acute respiratory infection in children and its safety is good, which is worth popularizing and applying in pediatrics.